RxDoctor Payments Data

Laurence Adams

Neurology · Colorado Springs, CONPI 1629070412

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,124 of the $11,597 with a category attached, or 87.3%. It is spread thinly across 60 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $4,227 and has fallen 97.1% since, to $122 in 2023.

$11,597in general payments, 2019–2025

Across 523 payments — averaging $22.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • AbbVie$937
  • Biogen$870
  • Novartis$852
  • Sanofi$583
  • Teva Pharmaceuticals USA, Inc.$524
  • plus $6K from 54 others
$54,660in research payments, 2019–2025

Across 20 payments — averaging $2733.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$30K
  • Regeneron$13K
  • Sanofi$10K
  • H. Lundbeck A S$1K
  • AbbVie$750

What the payments were for

  • Speaking & faculty fees$2032%
  • Travel & lodging$1,0339%
  • Food & beverage$10,12487%
  • Education$2362%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott19$1,610
AbbVie(2 entities)62$937
Biogen35$870
Novartis60$852
Sanofi29$583
Teva Pharmaceuticals USA, Inc.23$524
EMD Serono, Inc.24$448
Neurocrine Biosciences, Inc.17$370
Acorda Therapeutics, Inc10$319
Jazz Pharmaceuticals Inc.11$282
Eisai Inc.14$281
Biohaven Pharmaceuticals, Inc.9$265
Bristol Myers Squibb17$246
UCB, Inc.9$230
Amgen10$228
Lilly USA, LLC15$220
AstraZeneca10$201
CSL Behring6$181
Acadia Pharmaceuticals Inc7$179
Sunovion Pharmaceuticals Inc.11$167
SK Life Science, Inc.8$162
Livanova USA, Inc.8$161
Merz Pharmaceuticals, LLC5$161
Biohaven Pharmaceutical Holding Company Ltd.9$151
Genentech USA, Inc.6$136
Tanabe Pharma America, Inc.8$133
MDD US Operations, LLC6$122
Adamas Pharmaceuticals, Inc.6$119
Supernus Pharmaceuticals, Inc.5$100
Kyowa Kirin, Inc.4$86
Amneal Pharmaceuticals LLC3$71
Avanir Pharmaceuticals, Inc.4$70
Mallinckrodt Enterprises LLC4$69
Avion Pharmaceuticals3$69
Harmony Biosciences LLC2$68
Neurelis, Inc.3$65
Argenx US, Inc.3$60
GRT US Holding, Inc.2$53
Catalyst Pharmaceuticals, Inc.1$50
Octapharma USA, Inc.2$48
Akcea Therapeutics, Inc.3$45
Collegium Pharmaceutical, Inc.2$44
Banner Life Sciences, LLC2$42
Greenwich Biosciences, Inc.2$42
E.r. Squibb & Sons, L.L.C.3$41
Grifols USA, LLC2$41
Mallinckrodt Hospital Products Inc.2$38
Merz North America, Inc.1$36
Lundbeck LLC2$35
Saol Therapeutics Inc.2$34
ANI Pharmaceuticals, Inc.1$33
Ipsen Biopharmaceuticals, Inc2$33
Boston Scientific1$32
Nevro Corp.1$28
Alnylam Pharmaceuticals Inc.1$26
GE HealthCare1$21
Almatica Pharma LLC1$18
Vanda Pharmaceuticals Inc.1$17
Assertio Therapeutics, Inc.1$17
Medtronic1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,597 in reported general payments places this provider in the 75th percentile of 334 neurology providers in Colorado.

See all neurology providers in Colorado

Other neurology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →